Date published: 2026-5-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

CTDSP1 Inhibitors

CTDSP1 Inhibitors belong to a distinctive chemical class of compounds that specifically target and modulate the activity of the C-terminal domain small phosphatase 1 (CTDSP1) enzyme. This enzyme is a member of the protein phosphatase family, which plays a crucial role in cellular processes by dephosphorylating target proteins. CTDSP1, in particular, is involved in the regulation of RNA polymerase II-mediated transcription through its interaction with the C-terminal domain of RNA polymerase II. The inhibitors designed for CTDSP1 are meticulously crafted molecules that exhibit the capability to bind to the active site of the enzyme, obstructing its phosphatase activity. These inhibitors often possess a complex molecular structure that complements the binding pocket of CTDSP1, ensuring a high degree of selectivity and affinity. The modulation of CTDSP1 activity by these inhibitors presents an avenue for influencing cellular processes in which CTDSP1 plays a role. This chemical class has garnered considerable interest in scientific research due to its unveil novel insights into the intricate mechanisms of cellular signaling and transcriptional regulation.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cefaclor, Monohydrate

70356-03-5sc-205242
sc-205242A
500 mg
1 g
$84.00
$181.00
1
(0)

Cefaclor, Monohydrate (CAS 70356-03-5), inhibits CTDSP1, a key enzyme involved in cellular processes.

Fumagillin

23110-15-8sc-200377
sc-200377A
sc-200377B
sc-200377C
sc-200377D
1 mg
5 mg
25 mg
100 mg
500 mg
$104.00
$393.00
$541.00
$1363.00
$5212.00
1
(1)

Originally discovered as an inhibitor of angiogenesis, fumagillin has been investigated for its potential to inhibit CTDSPL1 and regulate transcriptional processes.

Cefaclor-d5

1426173-90-1sc-217851
1 mg
$390.00
(0)

Cefaclor-d5 (CAS 1426173-90-1) is a compound that acts as an inhibitor of CTDSP1, affecting its activity in cellular processes.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A is a fungal metabolite calcineurin and mitochondrial permeability transition pore opening inhibitor.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Used as an immunosuppressive and anticancer agent, sirolimus has been explored for its inhibitory effects on CTDSPL1 and its potential impact on transcriptional processes.

Myriocin (ISP-1)

35891-70-4sc-201397
10 mg
$150.00
8
(2)

Originally identified as a compound with antifungal properties, myriocin has been studied for its potential as a CTDSPL1 inhibitor.

Leflunomide

75706-12-6sc-202209
sc-202209A
10 mg
50 mg
$20.00
$83.00
5
(1)

Leflunomide is an inhibitor of Cox-2 and tyrosine kinase

Halofuginone

55837-20-2sc-507290
100 mg
$1775.00
(0)

This compound has shown promise as an inhibitor of CTDSPL1 and has been studied for its potential therapeutic applications.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Originally isolated from marine sponges, calyculin A has been examined for its ability to inhibit CTDSPL1 and influence transcriptional activity.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

An antibiotic with antifungal properties, cycloheximide has been explored for its potential to inhibit CTDSPL1 and modulate gene expression.